Increased antibody avidity and cross-neutralization of SARS-CoV-2 variants by hyperimmunized Tc-Bovine derived human immunoglobulins for treatment of COVID-19
Passive antibody immunotherapeutics directed against SARS-CoV-2 are promising countermeasures for protection and treatment of COVID-19. SARS-CoV-2 Variants of Concern (VOCs) and Variants
Read more